Related Experiment Video
Updated: May 26, 2026
Developing a Salivary Antibody Multiplex Immunoassay to Measure Human Exposure to Environmental Pathogens
Published on: September 12, 2016
[Development of multiplex microbead immunoassay for detection of specific antibodies against Cryptosporidium parvum]
Min Hou1, Xue-Li Du, Min-Jun Ji
1Department of Pathogenic Biology, Nanjing Medical University, Nanjing 210029, China.
Objective:
To develop a multiplex microbead immunoassay for detection of specific antibodies against Cryptosporidium parvum using recombinant proteins CP23, SA35 and SA40.
Methods:
By using purified recombinant proteins CP23, SA35 and SA40 as detected antigens, and bovine serum albumin (BSA) as internal control, the four proteins aforementioned were coupled with micro beads and MIA was developed. Then, the efficiency of the coupled proteins was tested, the difference between the single MIA method and the multiple MIA method was compared, and the difference between plates was also compared.
Results:
The purified proteins and BSA were coupled with microbeads successfully, and the MIA method was developed. Finally, the sensitivity and specificity of MIA method were confirmed.
Conclusions:
The multiplicate MIA method could be used to detect multiple antibodies after Cryptosporidium parvum infection, and the specificity and sensitivity of MIA are very high. The multiplicate MIA method can be one of the tools used in epidemiological survey.
Insights
A new multiplex microbead immunoassay (MIA) was developed to detect antibodies against Cryptosporidium parvum. This highly sensitive and specific method is effective for epidemiological surveys of Cryptosporidium parvum infections.
Area of Science:
- Immunology
- Parasitology
- Biotechnology
Background:
- Cryptosporidium parvum is a significant cause of diarrheal disease worldwide.
- Accurate detection of antibodies is crucial for understanding infection dynamics and for epidemiological surveys.
Purpose of the Study:
- To develop a multiplex microbead immunoassay (MIA) for the simultaneous detection of specific antibodies against Cryptosporidium parvum.
- To utilize recombinant proteins CP23, SA35, and SA40 as antigens for antibody detection.
Main Methods:
- Purified recombinant proteins (CP23, SA35, SA40) and bovine serum albumin (BSA) were coupled to microbeads.
- A multiplex microbead immunoassay (MIA) was developed and optimized.
- Efficiency of protein coupling, single vs. multiplex MIA, and plate variations were evaluated.
Main Results:
- Successful coupling of recombinant proteins and BSA to microbeads was achieved.
- The multiplex MIA method was successfully developed.
- High sensitivity and specificity of the developed MIA method were confirmed.
Conclusions:
- The multiplex MIA method effectively detects multiple antibodies post-Cryptosporidium parvum infection.
- The assay demonstrates high specificity and sensitivity, making it suitable for epidemiological surveys.
- This multiplex MIA serves as a valuable tool for public health surveillance of Cryptosporidium parvum.
